An increased frequency of follicular CD8+ and CD4−CD8− T cells was observed in tumor samples (Figure 3f,h), as well as a decreased percentage of activated follicular CD4+ and γδ+ T cells (Figure 3e,i). This evidence concerns the gene CD8A and neoplasm.